In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)

Table 1 Resistance spectrum of the ten clinical isolates of MRSA strains

Strain	Resistant	Intermediate	Susceptible
MRSA 008	PEN, AMP, OXA, CFZ, Cfx, P/T, ERY, AZM, CIP, LEV, NOR, CLI		VAN, LZD, TEI
MRSA 082	PEN, AMP, OXA, CFZ, Cfx, FUR, CPZ/S, P/T, ERY, AZM, ClA, CIP, LEV, NOR, CLI, RIF	FOS	VAN, LZD, TEI
MRSA 098	PEN, AMP, OXA, CFZ, Cfx, FUR, CPZ/S, P/T, ERY, AZM, CIP, LEV, NOR, CLI, RIF		VAN, LZD, TEI
MRSA 111	PEN, AMP, OXA, CFZ, Cfx, FUR, CPZ/S, P/T, ERY, AZM, CIP, LEV, NOR, CLI, RIF		VAN, LZD, TEI
MRSA 135	PEN, AMP, OXA, CFZ, Cfx, FUR, CPZ/S, P/T, ERY, AZM, CIP, LEV, NOR, CLI, RIF		VAN, LZD, TEI, FOS
MRSA 144	PEN, AMP, OXA, CFZ, Cfx, FUR, CPZ/S, P/T, ERY, AZM, CIP, LEV, NOR, CLI, RIF		VAN, LZD, TEI
MRSA 166	PEN, AMP, OXA, CFZ, Cfx, FUR, CPZ/S, P/T, ERY, AZM, CIP, LEV, NOR, CLI, RIF, P/T		VAN, LZD, TEI, FOS
MRSA 187	PEN, AMP, OXA, CFZ, Cfx, FUR, CPZ/S, P/T, ERY, AZM, CIP, LEV, NOR, CLI, RIF		VAN, LZD, TEI, FOS
MRSA 189	PEN, AMP, OXA, CFZ, Cfx, FUR, CPZ/S, P/T, ERY, AZM, CIP, LEV, NOR, CLI, RIF		VAN, LZD, TEI, FOS
MRSA 321	PEN, AMP, OXA, CFZ, Cfx, FUR, P/T, ERY, AZM, CIP, LEV, NOR, CLI, CPZ/S, RIF	GAT, CTH, FOS	VAN

PEN Penicillin, AMP Ampicillin, OXA Oxacillin, CFZ Cefazolin, Cfx Cefoxitin, FUR Cefuroxime, CTH Cefathiamidine, CPZ/S Cefoperazone/sulbactam, P/T Piperacillin/tazobactam, ERY Erythromycin, AZM Azithromycin, CIP Ciprofloxacin, GAT Gatifloxacin, LEV Levofloxacin, CLI clindamycin, RIF Rifampicin, CLA Clarithromycin, FOS Fosfomycin, LZD Linezolid, TEI Teicoplanin, VAN Vancomycin

ISSN: 2662-7671